Al-Ghorbani, M.; Alharbi, O.; Al-Odayni, A.-B.; Abduh, N.A.Y.
Quinoline- and Isoindoline-Integrated Polycyclic Compounds as Antioxidant, and Antidiabetic Agents Targeting the Dual Inhibition of α-Glycosidase and α-Amylase Enzymes. Pharmaceuticals 2023, 16, 1222.
https://doi.org/10.3390/ph16091222
AMA Style
Al-Ghorbani M, Alharbi O, Al-Odayni A-B, Abduh NAY.
Quinoline- and Isoindoline-Integrated Polycyclic Compounds as Antioxidant, and Antidiabetic Agents Targeting the Dual Inhibition of α-Glycosidase and α-Amylase Enzymes. Pharmaceuticals. 2023; 16(9):1222.
https://doi.org/10.3390/ph16091222
Chicago/Turabian Style
Al-Ghorbani, Mohammed, Osama Alharbi, Abdel-Basit Al-Odayni, and Naaser A. Y. Abduh.
2023. "Quinoline- and Isoindoline-Integrated Polycyclic Compounds as Antioxidant, and Antidiabetic Agents Targeting the Dual Inhibition of α-Glycosidase and α-Amylase Enzymes" Pharmaceuticals 16, no. 9: 1222.
https://doi.org/10.3390/ph16091222
APA Style
Al-Ghorbani, M., Alharbi, O., Al-Odayni, A.-B., & Abduh, N. A. Y.
(2023). Quinoline- and Isoindoline-Integrated Polycyclic Compounds as Antioxidant, and Antidiabetic Agents Targeting the Dual Inhibition of α-Glycosidase and α-Amylase Enzymes. Pharmaceuticals, 16(9), 1222.
https://doi.org/10.3390/ph16091222